|
Volumn 57, Issue 12, 2002, Pages 973-977
|
Synthesis antimicrobial and antifungal activity of some new 3-substituted derivatives of 4-(2,4-dichlorophenyl)-5-adamantyl-1H-1,2,4-triazole
|
Author keywords
Antifungal activity; Antimicrobial activity; Substituted 1,2,4 triazoles
|
Indexed keywords
3' [[4 (2,4 DICHLOROPHENYL) 5 (TRICYCLO[3.3.1.1 3,7 ]DECAN 1 YL) 4H 1,2,4 TRIAZOL 3 YL]MERCAPTOACETYLAMINO]SPIRO[9H FLUORENE 9,2' THIAZOLIDIN 4' ONE];
3' [[4 (2,4 DICHLOROPHENYL) 5 (TRICYCLO[3.3.1.1 3,7 ]DECAN 1 YL) 4H 1,2,4 TRIAZOL 3 YL]MERCAPTOACETYLAMINO]SPIRO[INDANE 1,2' THIAZOLIDIN 4' ONE];
4 [[4 (2,4 DICHLOROPHENYL) 5 (TRICYCLO[3.3.1.1 3,7 ]DECAN 1 YL) 4H 1,2,4 TRIAZOL 3 YL]MERCAPTOACETYLAMINO] 4 AZA 1 THIASPIRO[4,3]OCTAN 3 ONE;
4 [[4 (2,4 DICHLOROPHENYL) 5 (TRICYCLO[3.3.1.1 3,7 ]DECAN 1 YL) 4H 1,2,4 TRIAZOL 3 YL]MERCAPTOACETYLAMINO] 4 AZA 1 THIASPIRO[4,4]NONAN 3 ONE;
4 [[4 (2,4 DICHLOROPHENYL) 5 (TRICYCLO[3.3.1.1 3,7 ]DECAN 1 YL) 4H 1,2,4 TRIAZOL 3 YL]MERCAPTOACETYLAMINO] 4 AZA 1 THIASPIRO[4,5]DECAN 3 ONE;
[4 (2,4 DICHLOROPHENYL) 5 (TRICYCLO[3.3.1.1 3,7 ]DECAN 1 YL) 4H 1,2,4 TRIAZOL 3 YL]MERCAPTOACETIC ACID CYCLOBUTYLIDINE HYDRAZIDE;
[4 (2,4 DICHLOROPHENYL) 5 (TRICYCLO[3.3.1.1 3,7 ]DECAN 1 YL) 4H 1,2,4 TRIAZOL 3 YL]MERCAPTOACETIC ACID CYCLOHEXYLIDENE HYDRAZIDE;
[4 (2,4 DICHLOROPHENYL) 5 (TRICYCLO[3.3.1.1 3,7 ]DECAN 1 YL) 4H 1,2,4 TRIAZOL 3 YL]MERCAPTOACETIC ACID CYCLOPENTYLIDENE HYDRAZIDE;
[4 (2,4 DICHLOROPHENYL) 5 (TRICYCLO[3.3.1.1 3,7 ]DECAN 1 YL) 4H 1,2,4 TRIAZOL 3 YL]MERCAPTOACETIC ACID FLUORENYLIDENE HYDRAZIDE;
[4 (2,4 DICHLOROPHENYL) 5 (TRICYCLO[3.3.1.1 3,7 ]DECAN 1 YL) 4H 1,2,4 TRIAZOL 3 YL]MERCAPTOACETIC ACID INDANYLIDENE HYDRAZIDE;
ANTIFUNGAL AGENT;
ANTIINFECTIVE AGENT;
HYDRAZINE DERIVATIVE;
HYDRAZONE DERIVATIVE;
N [[4 (2,4 DICHLOROPHENYL)ADAMANTYL 1H 1,2,4 TRIAZOL 3 YLMERCAPTOACETYL]HYDRAZINE];
PYRROLE DERIVATIVE;
UNCLASSIFIED DRUG;
4 (2,4 DICHLOROPHENYL) 5 ADAMANTYL 1H 1,2,4 TRIAZOLE;
4-(2,4-DICHLOROPHENYL)-5-ADAMANTYL-1H-1,2,4-TRIAZOLE;
TRIAZOLE DERIVATIVE;
ANTIFUNGAL ACTIVITY;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
BACILLUS SUBTILIS;
CANDIDA ALBICANS;
CONTROLLED STUDY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ESCHERICHIA COLI;
INFRARED RADIATION;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
PROTON NUCLEAR MAGNETIC RESONANCE;
PSEUDOMONAS AERUGINOSA;
STAPHYLOCOCCUS AUREUS;
CHEMISTRY;
DRUG EFFECT;
MICROBIOLOGICAL EXAMINATION;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
SYNTHESIS;
ANTI-BACTERIAL AGENTS;
ANTI-INFECTIVE AGENTS;
ANTIFUNGAL AGENTS;
CANDIDA ALBICANS;
MAGNETIC RESONANCE SPECTROSCOPY;
MICROBIAL SENSITIVITY TESTS;
STAPHYLOCOCCUS AUREUS;
TRIAZOLES;
|
EID: 0036904422
PISSN: 0014827X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-827X(02)01227-2 Document Type: Article |
Times cited : (126)
|
References (9)
|